换一批
换一批Comparison of effectiveness and safety of imipenem/clavulanate- versus meropenem/clavulanate-containing regimens in the treatment of MDR- and XDR-TB.
作者：
Simon,Tiberi [1]
;
Giovanni,Sotgiu [2]
;
Lia,D'Ambrosio [3]
;
Rosella,Centis [4]
;
Marcos,Abdo Arbex [5]
;
Edith,Alarcon Arrascue [6]
;
Jan Willem,Alffenaar [7]
;
Jose A,Caminero [8]
;
Mina,Gaga [9]
;
Gina,Gualano [10]
;
Alena,Skrahina [11]
;
Ivan,Solovic [12]
;
Giorgia,Sulis [13]
;
Marina,Tadolini [14]
;
Valentina,Alarcon Guizado [15]
;
Saverio,De Lorenzo [16]
;
Aurora Jazmín,Roby Arias [17]
;
Anna,Scardigli [18]
;
Onno W,Akkerman [19]
;
Alena,Aleksa [20]
;
Janina,Artsukevich [20]
;
Vera,Auchynka [11]
;
Eduardo Henrique,Bonini [5]
;
Félix Antonio,Chong Marín [17]
;
Lorena,Collahuazo López [17]
;
Gerard,de Vries [21]
;
Simone,Dore [22]
;
Heinke,Kunst [23]
;
Alberto,Matteelli [13]
;
Charalampos,Moschos [9]
;
Fabrizio,Palmieri [10]
;
Apostolos,Papavasileiou [9]
;
Marie-Christine,Payen [24]
;
Andrea,Piana [22]
;
Antonio,Spanevello [25]
;
Dante,Vargas Vasquez [26]
;
Pietro,Viggiani [16]
;
Veronica,White [27]
;
Alimuddin,Zumla [28]
;
Giovanni Battista,Migliori [29]
作者单位：
Division of Infection, Barts Healthcare NHS Trust, London, UK These authors contributed equally to this work.
[1]
Clinical Epidemiology and Medical Statistics Unit, Dept of Biomedical Sciences, University of Sassari - Research, Medical Education and Professional Development Unit, AOU Sassari, Sassari, Italy These authors contributed equally to this work.
[2]
WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Tradate, Italy Public Health Consulting Group, Lugano, Switzerland These authors contributed equally to this work.
[3]
WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Tradate, Italy These authors contributed equally to this work.
[4]
University Center of Araraquara, Sao Paulo, Brazil Hospital Nestor Goulart Reis, Sao Paulo State Secretary of Health, Sao Paulo, Brazil.
[5]
International Union against Tuberculosis and Lung Disease (The Union), Lima, Peru MDR-TB Unit, Tuberculosis Division, International Union against Tuberculosis and Lung Disease (The Union), Paris, France.
[6]
University of Groningen, University Medical Center Groningen, Dept of Clinical Pharmacy and Pharmacology, Groningen, The Netherlands.
[7]
MDR-TB Unit, Tuberculosis Division, International Union against Tuberculosis and Lung Disease (The Union), Paris, France Pneumology Dept, Hospital General de Gran Canaria "Dr. Negrin", Las Palmas de Gran Canaria, Spain.
[8]
MDR-TB Unit, Athens Chest Hospital Sotira, National Referral Centre for Mycobacteria, Athens, Greece.
[9]
Respiratory Infectious Diseases Unit, National Institute for Infectious Diseases "L. Spallanzani", Rome, Italy.
[10]
Republican Research and Practical Centre for Pulmonology and Tuberculosis, Minsk, Belarus.
[11]
National Institute for TB, Lung Diseases and Thoracic Surgery, Vysne Hagy, Catholic University Ruzomberok, Ruzomberok, Slovakia.
[12]
University Dept of Infectious and Tropical Diseases, WHO Collaborating Centre for TB/HIV Co-infection and for TB Elimination - University of Brescia and Brescia Spedali Civili General Hospital, Brescia, Italy.
[13]
Unit of Infectious Diseases, Dept of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, Bologna, Italy.
[14]
National Tuberculosis Control Programme, Ministry of Health, Lima, Peru.
[15]
AOVV E. Morelli Hospital, Reference Hospital for MDR and HIV-TB, Sondalo, Italy.
[16]
National Tuberculosis Control Programme, Pulmonology Hospital Alfredo J. Valenzuela, Guayaquil, Ecuador.
[17]
MDR-TB Unit, Tuberculosis Division, International Union against Tuberculosis and Lung Disease (The Union), Paris, France.
[18]
University of Groningen, University Medical Center Groningen, Dept of Pulmonary Diseases and Tuberculosis; TB Center Beatrixoord, Groningen, The Netherlands.
[19]
Educational Institution "Grodno State Medical University", Grodno, Belarus.
[20]
KNCV Tuberculosis Foundation, The Hague, The Netherlands.
[21]
Clinical Epidemiology and Medical Statistics Unit, Dept of Biomedical Sciences, University of Sassari - Research, Medical Education and Professional Development Unit, AOU Sassari, Sassari, Italy.
[22]
Dept of Respiratory Medicine, Queen Mary University, London, UK.
[23]
Division of Infectious Diseases, CHU Saint-Pierre, Université Libre de Bruxelles (ULB), Brussels, Belgium.
[24]
Pneumology Unit, Fondazione Maugeri, IRCCS, Tradate, Italy Dept of Clinical and Experimental Medicine, University of Insubria, Varese, Italy.
[25]
National Hospital Hipólito Unanue, Public Health Institute, Ministry of Health, Lima, Peru.
[26]
Dept of Respiratory Medicine, Barts Healthcare NHS Trust, London, UK.
[27]
Division of Infection and Immunity, University College London and NIHR Biomedical Research Centre, UCL Hospitals NHS Foundation Trust, London, UK.
[28]
WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Tradate, Italy giovannibattista.migliori@fsm.it.
[29]
主题词
成年人(Adult);抗结核药(Antitubercular Agents);棒酸(Clavulanic Acid);队列研究(Cohort Studies);疗效比较研究(Comparative Effectiveness Research);抗药性, 细菌(Drug Resistance, Bacterial);广泛耐药结核(Extensively Drug-Resistant Tuberculosis);女(雌)性(Female);人类(Humans);亚胺培南(Imipenem);男(雄)性(Male);中年人(Middle Aged);痰(Sputum);噻烯霉素类(Thienamycins);时间因素(Time Factors);治疗结果(Treatment Outcome);结核, 抗多种药物性(Tuberculosis, Multidrug-Resistant)
DOI
10.1183/13993003.00214-2016
PMID
27076583
发布时间
2018-12-02
- 浏览10
The European respiratory journal
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
